SM T/2026/000311 20230525 US 202363443269 P 20230203 US 202363455861 P 20230330 US 202363440297 P 20230120 US 202263345727 P 20220525 HIBERCELL, INC.
619 West 54th Street, 8th Floor, New York, NY 10019, US US
US BOSE, Nandita
, New York, New York 10019, US US
RAMURTHY, Savithri
, New York, New York 10019, US US
TAMEIRE, Feven
, New York, New York 10019, US US
IGLESIAS, Jose
, New York, New York 10019, US US
SURGULADZE, David
, New York, New York 10019, US US
OLIVER-SHAFFER, Patricia
, New York, New York 10019, US US
MULVIHILL, Mark J.
, New York, New York 10019, US US
GARGANO, Michele
, New York, New York 10019, US US
FERRIERO, Paolo
Via del Serrone, 109, 47897 Fiorentino RSM, SM SM
MODULATORE DI GCN2 PER IL TRATTAMENTO DI TUMORI SOLIDI AVANZATI O CANCRO DEL SANGUE GCN2 MODULATOR FOR TREATING ADVANCED SOLID TUMORS OR BLOOD CANCER 20260723 2026000311 23 PCT/23733583.1 20230525 EP WO/4531857 20260311 20230525 20260723 Brevetti EPO